Arbutus to Report Third Quarter 2024 Financial Results and Provide Corporate Update
23. Oktober 2024 07:30 ET
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), (“Arbutus” or the “Company”) a clinical-stage biopharmaceutical company leveraging its extensive...